MMA Media Download PDF
  • 326
  • 27
BioSpectrum Asia May 2019
3Ps augmenting drug discovery in APAC

Beyond meeting the needs of global pharma in simply providing access to patient pools and lower operational costs, the Asia-Pacific (APAC) region is also poised to realize the potential of a thriving biotechnology sector that is driving innovation on its own. APAC is gaining the experience and infrastructure needed to support the global biotech industry by performing work and fostering innovation through public private partnership (3Ps) that is moving up the pharmaceutical value chain.
View Text Version Category : 26
  • Follow
  • 0
  • Embed
  • Share
  • Upload
Related publications